Vimarsana
Biggest News Aggregation in the World

Page 5 - Vr App News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vr App. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vr App Today - Breaking & Trending Today

KQEH Nightly Business Report January 29, 2016 - Vimarsana News

KQEH Nightly Business Report January 29, 2016

Amazon. And its stock is paying the price. The Online Retail behemoth earned a dollar a share. That translates into its largest quarterly profit in its 19year history. But investors wanted more, a lot more. Expects were 1. 56 per share. Revenue came in shy of estimates despite rising more than 20 from a year ago. And as for its shares they were punished initially after that report. John ford has more on amazons results. Big number to watch in amazon earnings is the top line revenue wall street was looking for, 35. 9 billion in revenue, they got 37. 7 billion. Eps missed also. Its overall growt...

Three EU iPhone App Store options: which is best for developers - Vimarsana News

Three EU iPhone App Store options: which is best for developers

Even as EU developers get the option to sell apps outside of the App Store, there are some who should stay with Apple, and a few who should go it alone. Here's the breakdown.

Apple AR headset in 2022 will have M1-level processing power, says Ming-Chi Kuo - Future Apple Hardware Discussions on AppleInsider Forums - Vimarsana News

Apple AR headset in 2022 will have M1-level processing power, says Ming-Chi Kuo - Future Apple Hardware Discussions on AppleInsider Forums

Analyst Ming-Chi Kuo has reaffirmed predictions that the first Apple AR headset will launch at the end of 2022, but now says it will be a much more powerful device than expected.

This US-based startup is helping scientists use VR to study coronavirus; here's how - Vimarsana News

This US-based startup is helping scientists use VR to study coronavirus; here's how

Through its virtual reality (VR) app, US-based startup Nanome licenses its technology to scientists in their research of diseases as well as pharma companies aiming to design new drugs